NACCT DAY 1. Saturday, September 13, 2008
4:00 PM–5:00PM Platform Session 1: Poison Center
Abstracts #1–#4
1.Poison Centers and Medical Cost Avoidance: Revisiting the Concept $7 Saved for Every $1 Spent. Hilton J, Wahl M.
2. Health Care Costs Associated with the Management of Childhood Poisonings: Impact of the Poison Control Center. Kim R, Lee K, Hiatt P.
3. Analysis of Data from a Novel Drug Identification Service. Doyon S, Anderson BA, Welsh CJ, Klein-Schwartz W, Hayes BD.
4. Hazardous Materials Incidents: Should Poison Centers Be More Involved?. Sutter ME, Hon S, Chang A, Schwartz M, Algren DA, Schier J, Lando J.
5:00 PM–6:00 PM Platform Session 2: Toxicity & Laboratory
Abstracts #5–#9
5. Quantitative Bedside Screening Test for Methaemoglobin. Shihana HSF, Dissanayake DM, Dawson A.
6. The Effect of Acetadote on Prothrombin Time in Plasma Samples from Healthy Subjects. Pizon AF, Jang DH, Wang HE.
7. Fomepizole Inhibit Diethylene Glycol Toxicity and Metabolism in Rats. McMartin KE, Besenhofer LM, Cain M, Latimer B.
8. Escitalopram Causes Fewer Seizlures in Human Overdose Than Citalopram. Yilmaz Z, Rauber C, Sauer O, Stedtler U, Prasa D, Seidel C, Hackl E, Hoffmann P, Gerber G, Bauer K, Kupferschmidt H, Kullak G, Wilks M.
9. Probable Benefit of Hyperinsulinemia-Euglycemia and Hyperventilation Oxygenation on Aluminium Phosphide Poisoning. Hassanian-Moghaddam H.
NACCT DAY 2. Sunday, September 14, 2008
11:00 AM–12:00 PM Platform Session 3: Basic Science
Abstracts #10–#13
18. Effect of Cyclodextrin Infusion in a Rat Model of Verapamil Toxicity. Mottram AR, Aks SE, Bryant S, Lu J, Kalimullah E.
19. Treatment of Experimental Verapamil Poisoning with Levosimendan and 4-Aminopyridine. Graudins A, Ka Ling Wong K.
20. Glucose Uptake Sensitivity in Cardiac and Adipose Cells Exposed to Three Classes of Calcium Channel Blockers. Bechtel LK, Charlton NP, Holstege CP.
21. Olanzapine Attenuates Cocaine Toxicity in a Mouse Model. Krier S, Cleveland NJ, Heard K.
11:00 AM–12:00 PM Platform Session 4: Education
Abstracts #14 – #17
14. A Medicine Safety Needs Assessment Conducted with Directors of Programs for Older Adults. Schwartz L, Martinez L, Louie J, Mercurio-Zappala M, Howland MA, Hoffman RS.
15. The Success of Poison Prevention Education Technology. Dance V.
16. Magnet, Memory or Referral?. Miller RL, Heinen MA.
17. The Impact of Public Education Efforts on Wyoming's Call Volume – “I've Been Everywhere Man”. McVoy J, Fladby C, Jacobitz K, Meza J.
9:00 AM–3:00 PM Poster Session I
(Authors with posters Abstracts #18–#111
10:00 AM–11:00 AM)
18. Raising Poison Control Centers' Visibility through Multi-Disciplinary Interactions. Badillo R, McGoodwin L, Schaeffer S.
19. Benzonatate Ingestion Reported to the National Poison Center Database System (NPDS). Spiller HA, Winter ML, Griffith JRK.
20. A Case of Life-Threatening Cesium Chloride Poisoning Treated by Prussian Blue. Chan YC, Chan CK, Tse ML, Lau FL.
21.Envenomation by the Malayan Spitting Cobra, Naja Naja Sputatrix: A Case Series. Seifert SA, Kunkel SJ, Nogar J.
22. Law Enforcement Drug Identifications – A Growing Concern for Poison Centers. Cantrell FL, Clark RF.
23. Poison-Related 911 Calls Managed by Emergency Medical Dispatch (EMD) and Poison Control Center (PCC) Services. Kuan RK, Hiatt PH, Sporer KA, Kearney TE.
24. Role of N-Acetyl Cycteine in Treatment of Organophosphate Poisoning. Shadnia S, Sasanian G, Ashrafivand S.
25. Tetramethylammonium Hydroxide Poisoning: An Emerging and Potentially Life-Threatening Hazard in Semi-Conductor and Photoelectric Industries. Lin CC, Yang CC, Ger J, Deng JF.
26. Toddler with Ventricular Tachycardia after Diphenhydramine Overdose. Mazor SS, Guse SE, Chun T.
27. Ciguatera Poisoning Successfully Treated with Delayed Mannitol. Schwarz ES, Mullins ME, Brooks CB.
28. Atypical Clinical Course Following Rattlesnake Envenomation. Ruha AM.
29. A Retrospective Review of Unintentional Pediatric Buprenorphine Ingestions Reported to a Regional Poison Center. Kurta DL, Krenzelok EP.
30. Bupropion Overdose Causing Serotonin Syndrome: A Retrospective Chart Review. Cimikoski WJ, Salman NH, Kirschner RI, ODonnell SJ, Donovan JW.
31. Analysis of Biological Samples and Beads from a Case of Bindeez Beads (Aqua Dots) Ingestion. Davies S, Button J, Dargan PI, Ovaska H, Ramsey J, Holt DW, Wood DM.
32. Yam Bean Seed Poisoning with Diffused Brain Injury. Hung D.
33. Healthcare Facility Referral of Asymptomatic Pediatric Coin Ingestions. Li DA, Roe DI, Lepik KJ.
34. The Puget Sound Call Center Coordination Project – Planning for a Public Health Emergency. Cropley JM, Hurley WT, Robertson WO.
35. Toxicosurveillance through a Regional Teleconference: The Washington and Oregon Colchicine Cases. Hurley WT, Horowitz BZ, Robertson WO.
36. Lethal Anaphylaxis to Snake Venom. Greene SP, Seifert SA, Haynes, Jr. JF, Baeza III SH.
37. Snake Envenomation in Pregnant Patients during the Fab Antibody Fragment Antivenom Era. Barry JD, Chin EJ, Borys DJ.
38. Delayed Coagulopathy Secondary to Crotaline Envenomation Following Initial Control with Crotalidae Polyvalent Immune Fab: A Retrospective Case Series. Miller AD, Young MC, DeMott MC, Ly BT, Schneir AB, Clark RF.
39. A Profile of Calls from Nursing Homes to a Poison Center. Naumovski J, Mrvos R, Krenzelok EP.
40. Lead Toxicity from an Ayurvedic Medication. Quan D, Brooks DE.
41. Kratom: A Case of a Legal High. Roche KM, Hart K, Sangalli B, Lefberg J, Bayer M.
42. Selenosis from Nutritional Supplement Formulation Error. Sutter ME, Thomas JD, Caldwell KL, Makhmudov A, Morgan BW.
43. Correlation of Altered Mental Status with Toxic Acetaminophen Exposure in Suicidal Patients Taking Acetaminophen with Hydrocodone. Roth BA, Fernandez MC, Forrester MB.
44. Leaded and Unleaded: The Story of an Old Gunshot Wound. Miller JB, Garcia AJ, Baltarowich L, Dougherty P.
45. Whole Bowel Irrigation for Massive Jimson Weed Seed Ingestion. Blume-Odom CM, Scalzo AJ, Weber JA.
46. Interstitial Nephritis Following an Acute Acetaminophen Overdose. Young MC, Miller AD, Krous HF, Schneir AB.
47. Correlation of the Surrogate Markers of Anion Gap, Osmolar Gap, and Drowsiness to Outcome in a Large Case Series of Ethylene Glycol Exposures. Roth BA, Forrester MB, Labat MJ.
48. Agitation with Oral Baclofen Overdose. Farooqi MF, Seifert SA.
49. Evaluation of Zolpidem Exposures in the Pediatric Population. Griffith JRK, Phan H, Casavant MJ, Nahata MC, Baker SD.
50. Half-Life of Zonisamide in a Patient with an Intentional Overdose. Van Roo J, Leikin JB, Kanter MZ.
51. Poisoning Hazards of Lamp Oils. Burda A, Sims J, DesLauriers C, Leikin J.
52. Drugs Associated with Seizure in Patients Admitted to a Toxicology Treatment Center. Kirschner RI, Cimikoski WJ, Squillante CM, Donovan JW.
53. Increased Poison Center Call Volume after Education to Elders. Chambers-Emerson J, Lewis-Younger CR.
54. Survival of Verapamil-Poisoned Rats Treated with Triiodothyronine. Lynch MJ, Katz KD, Callaway CW, Logue ES, Pizon AF.
55. Elevated Osmolal Gap after Mouthwash Ingestion. George M, Al-Duaij N.
56. Dangers of Opioid-Containing Cough and Cold Drug Use in Children Less Than Six Years of Age. Green JL, Banner W, Bond R, Kauffman R, Manoguerra A, Palmer RB, Paul IM, Rumack B, Winston D, Dart RC.
57. A Profile of Drug Identification Calls. Krenzelok EP, Mrvos R.
58. Poison Control Centers' Role in the Glow Product-Related Outbreak Detection: Implications for Comprehensive Surveillance System. Chu AF, Ruck B, Marcus S.
59. Interactive Voice Response (IVR) To Manage Drug Identification Calls. Krenzelok EP, Mrvos R, Bronstein AC.
60. Increasing Consultation by Specialists in Poison Information Using a Productivity Metric. Lewis-Younger CR.
61. Impact of an Antidepressant Black Box Warning on Suspected Attempted Suicides Reported to Poison Control Centers. Forrester MB, Snodgrass WR.
62. Acetaminophen Poisoning with a Difference. Chan BS, Graudins A, Chiew A.
63. Surveillance of Maternal-Fetal Exposures in California. Broderick M, Dodd-Butera T, Clark RF, Chambers C.
64. Severe Acetaminophen Poisoning with Therapeutic Dosing in a Child with an Undiagnosed Genetic Disorder. Rangan C.
65. Recovery of a Symptomatic Patient Abusing Zolazepam. Ragone SP, Skinner CG, Morgan BW, Geller RJ, Schwartz MD.
66. Puffer Fish (Tetrodotoxin) Poisoning in Chicago, IL. Thompson TM, Cohen N, Brinker N, Pearlman M, Wahl M.
67. Beware the Pygmy Slow Loris?. Kalimullah EA, Schmidt SM, Schmidt MJ, Lu JJ.
68. Delayed Pulmonary Edema from Oxycodone HCL in a 14 Month Old Child. Caraccio TR, Luboweicki D, Flori J, Stanton C, McGuigan MA, Yum EK, McFee R.
69.Pharmacists Preventing Opioid-Induced Adverse Drug Events: Case-Control Versus Voluntary ADE Reporting. Raymo LL, Wolowich WR, Camejo M, Rodriguez JC, Prieto ML, Connors JT, Duenas SR, Hawkins-Locke C.
70. The Use of “Clinical Effect-Other” in the Coding of Poison Center Cases. Lintner CP, Bangh SA.
71. Beetlejuice Beetlejuice Beetlejuice!. Kwon SK, Kinnan MR.
72. A Pilot Study Using a New Point of Care Test for Methanol. Kapur BM, Thompson MA.
73. Sotalol-Induced Tosades de Pointes Treated wtih Hemodialysis. Zebuda C, Majlesi N, Greller HA, Lee DC, Su MK, Chan GM.
74. Falsely Elevated Lactate Measurement after Ethylene Glycol Ingestion. Lawrence DT, Bechtel LK, Charlton NP, Holstege CP.
75. Black Widow Envenomation Presenting as Possible Barbiturate Withdrawal. Schaeffer SE, McGoodwin PL, Badillo RB.
76. Therapeutic Misadventure of High Dose Insulin without Adverse Effects. Engebretsen KM, Holger JS, Harris CR.
77. Buprenorphine-Induced Respiratory Depression Reversed by Naloxone in a 2-Year-Old. Truitt C, Majlesi N, Greller H, Chan G, Lee D, Su M.
78.Anuric Renal Failure, Pancreatitis, and Acute Respiratory Distress Syndrome in Bothrops venezuelensis Envenomation. Hayes AK, Mullins ME, Keyler DE, Halcomb SE.
79. Severe Myoclonus from Pregabalin (Lyrica) Due to Chronic Renal Insufficiency. Murphy NG, Mosher L.
80. A Two-Year Review of Pediatric Liquid Hand Sanitizer Ingestions. Alsop JA, Daubert GP.
81. Phenibut Withdrawal – A Novel “Nutritional Supplement”. Odujebe OA, Hoffman RS, Nelson LS.
82. The Use of “Therapy-Other” in the Coding of Poison Center Cases. Bangh SA, Lintner CP.
83. Metformin Overdose in an Adolescent with Severe Metabolic Acidosis & Hyperlacticacidemia Treated with Bicarbonate-Buffer Hemodialysis. Scalzo AJ, Andreone TA, Wood EG, Weber JA.
84. A Retrospective Study of Fluoxetine Unintentional Ingestions: Establishing a Toxic Dose in the Pediatric Population. Siptak CM, Banerji S, Bronstein AC.
85. Lack of Conversion to Inorganic Arsenic after Ingestion of a Monosodium Acid Methanearsonate Herbicide. Kleiman RJ, Morgan BW, Osterloh JD, Dell'Aglio DM, Caldwell KL, Freedman CG, Verdon CP, Thomas JD.
86. Application of Lean Theory to Poison Center Quality Management Processes. Schaetzle LA, Bronstein AC, Neil RM, Hesse CL.
87. Mistaken Oral Ingestion of Inhalational Medications for Chronic Obstructive Pulmonary Disease (COPD). Varney SM, Mrvos R, Bronstein AC.
88. Life Threatening Anemia from Chronic Aluminum Ingestion Via Fabric Softener Sheets. Harchelroad FP, Cammarata C.
89. Massive Ethylene Glycol Ingestion Treated with Fomepizole Alone. Buchanan JA, Alhelail MA, Cetaruk EW, Schaeffer TH, Palmer R, Brent J.
90. Acute Respiratory Failure and Death Associated with Acrolein Exposure during Routine Application. Thomas KC, Redmond M, Thomsen G, Crouch BI, Caravati EM.
91. Flower Power Gone Bad. Kimball TA, Eubank P, Lewis-Younger C.
92. Falsely Elevated Lactate Level in Ethylene Glycol Poisoning: A Case for Better Understanding the Limitations of Our Laboratory Equipment. Cooperman JJ, Keadey M, Morgan BW.
93. Iatrogenic Ethanol Intoxication. Arroyo AM, Furbee RB.
94. Severe Health Impairment of a 6-Week-Old Infant Related to the Ingestion of Boiled Poppy Seeds. Hahn A, Michalak H, Begemann K, Meyer H, Burger R, Luch A.
95. Massive Ibuprofen Ingestion Resulting in Coagulopathy, Hypotension, and Coma without Significant Renal Failure. Cole JB, Roberts DJ, Bangh SA.
96. Deafness and Hepatotoxicity after an Acute Intentional Ingestion of Monosodium Methanearsenate. Wessels CL, Barker KA, Williams SR.
97. Continuous Pralidoxime Infusion in Organophosphate Toxicity: A Case Report. Pierog JE, Mancinelli MJ, Kane KE.
98. Content Analysis of YouTube as Source of Toxicologic Information. Akhtar J, Lo AM, Suffoletto B, Krenzelok EP.
99. Ethylene Glycol Poisoning with Biphasic, Rapid Elimination. Beuhler MC, Kerns WP.
100. Are We Ready for Prime Time? Prenatal Lead Screening. Calello DP, Chinnakaruppan N, Fleischer G, Marcus S.
101. Lithium Toxicity Reported to a Statewide Poison Control System. Offerman SR, Alsop JA, Lee J, Holmes JF.
102. Symptomatic Pediatric Zolpidem Exposures with Elevated Serum Concentration. Feng S, Goto CS, Velez LI.
103. Unique Management of Isolated Yew Berry Toxicity. Pierog JE, Kane BG, Donovan JW.
104. Muscular Spasm with Therapeutic Doses of Cang Er Zi. West PL, McKeown NJ, Hendrickson RG.
105. Delayed Recrudescence of ASA to Toxic Levels after Cessation of Bicarbonate Therapy. West PL, Horowitz BZ.
106. Ethanol-Induced Transient Myocardial Dysfunction in a Three Year Old. Kapadia KJ, Marcus SM, Ruck BE, Rella JG.
107. Clinical Effects of Epinephrine Auto Injector Exposures. Maloney GE, Wahl M.
108. Duplication/Ultrarapid Metabolism of Cytochrome P450 2D6 (CYP2D6) as Possible Cause for Dextromethorphan (DM)/Dextrorphan (DX) Overdose in a Child. Lowry JA, Gaedigk A, Pearce RE, Pierson MS, Leeder JS.
109. Inocybe Mushroom Poisoning: A Case Series with Exact Species' Identification. Lurie Y, Wasser SP, Lavon O, Bentur Y.
110. Effects of Adenosine Receptor Antagonists on Survival in Amitriptyline-Poisoned Mice. Kalkan S, Hocaoglu N, Akgun A, Oransay K, Ergor G, Tuncok Y.
111. Unusual Manifestations after Inadvertant Pediatric Ingestion of Pyridostigmine. Hughes K, Bilden EF, Keeling FE.
NACCT DAY 3. Monday, September 15, 2008
4:00 PM–5:00 PM Platform Session 5: Epidemiology
Abstracts #112–#115
112. Regional and Temporal Variation in Methamphetamine-Related Incidents: Applications of Geographic Information Systems and Spatial Scan Statistics. Sudakin DL, Power LE.
113. Validation of Putative Substances in Poisonings Involved in Fatal Poisonings. Hansen CK, Kashani J, Ruck B, Marcus S.
114. NPDS Data: Situational Awareness of an Emerging Poisoning Epidemic. DesLauriers C, Wahl M.
115. Use of Antivenin for Snake Bites Reported to US Poison Centers (PC). Spiller HA, Bosse GM, Ryan ML.
9:00 AM–3:00 PM Poster Session II
(Authors with posters Abstracts #116–#207
10:00 AM– 11:00 AM)
116. Who Are We Serving with Pill ID Requests?. Spiller HA, Griffith JRK.
117. High Pressure Injection of Pepper Spray. Cooper SJ, Hurley WT, Amott SJ.
118. Using a Media Buyer To Promote Poison Center. Booth KM, Hurley WT.
119. Toxicity from Duloxetine Ingestion. Griffith JRK, Spiller HA, Weber JA, Lintner CP, Casavant MJ, Baker SD.
120. Mechanisms of Adverse Reactions to Intravenous Acetylcysteine in Acetaminophen Overdose. Bateman DN, Pakravan N, Waring WS, Ludlam C, Megson IL, Sharma S.
121. Differential Toxicological Diagnoses Using a Computerized Knowledge-Based Model. Schipper JD, Schauben JL, Dankel II DD, Arroyo AA, Sollee DR.
122. Demographics of Toxic Exposures Presenting to Three Public Hospital Emergency Departments in Singapore 2001–2003. Ponampalam R, Tan HH, Ng KC, Lee WY.
123. Drug Combinations Associated with Serotonin Syndrome in Patients Admitted to a Toxicology Treatment Center. Kirschner RI, Cimikoski WJ, Donovan JW.
124. Reversible Bilateral Hearing Loss after Heroin Overdose. Simpson S, Murphy C, Mullin DK.
125. Acetone Clearance Improved with Hemodialysis. Wheeler MT, Pizon AF, Lynch M, Katz K, Schwartz A.
126. Trends in Hypoglycemic Drug Exposures Reported to Six Poison Control Centers. Forrester MB, Garrison JR.
127. Gamma Hydroxybutyrate (GHB) Abuse Trends: Impact of U.S. Regulatory Controls. Anderson IB, Kim-Katz SY, Dyer JE, Blanc PD.
128. Coma Following Toxic Topiramate Ingestion. Lynch MJ, Pizon AF, Krasowski M.
129. Clinical Features of Montelukast Ingestion Reported to a National Poisons Service. Adams RD, Good AM, Waring WS, Bateman DN.
130. Survival after Massive Diphenhydramine Ingestion Requiring Hemodialysis in a Toddler. McKeown NJ, West PL, Horowitz BZ.
131. Inappropriate Use of Physostigmine in TCA Toxicity: An Online Medical Reference May Be Paritally Responsible. Cocuzza T, Ruck B, Marcus S, Rella JG.
132. Highest Reported Serum Topiramate Level with Survival. Greene SC, O'Connor AD.
133. Outcomes Following Accidental Pediatric Ingestions of (Dextro-) Amphetamine and Methylphenidate. Sawyers B, Thole D, Lovecchio F, Brooks DE.
134. Occupational Acute Pulmonary Edema Following Refrigeration Coil Deicing. McKeown NJ, Burton BT.
135. Public Health Savings from a Regional Poison Center. Lovecchio F, Curry S, Waszolek K, Klemens J, Hovseth K, Glogan D.
136. Pediatric Ingestions of Triptans. DesLauriers C, Burda A.
137. Current Trends in the Risk Assessment of 650mg Tylenol Extended Relief. Daubert GP.
138. Myelin Basic Protein in the CSF May Represent a Predictive Marker of Delayed Encephalopathy from CO Poisoning. Ide T, Kamijo Y, Ide A, Yoshimura K, Soma K.
139. Fatality Following Drotaverine Overdose. Culley KA, Michels JE, Richardson WH.
140. Validity of the AAPCC Atypical Antipsychotic Ingestion Guideline for Quetiapine. Blair HW, Warwick KM, Morgan DL, Borys DJ.
141. Secular Trends in Adverse Exposure Outcomes from the National Poison Data System, 2000–2007. Spyker DA, Marcus SM, Bronstein AC, Rumack BH.
142. Factors Associated with Poison Related Fatality: A Case Control Study. Manini AF, Nelson LS, Olsen D, Fulton J, Hoffman RS.
143. Zopiclone-Induced Methemoglobinemia and Renal Impairment. Kung SW, Chan YC, Lau FL.
144. Pediatric Hypertensive Encephalopathy after Abrupt Withdrawal of Guanfacine. Hashikawa AN, Kostic MA, Gummin DD.
145. Coma and Recurrent Asystole Following Unintentional Self-Injection of Xylazine. Curry SC, Gresham HW, Jackson S.
146. Delayed Ischemic Cerebrovascular Accident Following Mojave Rattlesnake Envenomation. Greene SC, Ruha AM.
147. Clinical Effects Following Acute Donepezil (Aricept) Ingestion by Young Children. Deitche AL, Deitche WS, Bebarta VS, Borys DJ, Morgan DL.
148. Pediatric Ingestions of Pramipexole and Ropinirole. DesLauriers C, Burda A, Wahl M.
149. The Current Role of Clinical Toxicology and Poison Centers in Local and State Public Health. Sutter ME, Bronstein AC, Heard SE, Barthold CL, Algren DA, Lando J, Shier JG.
150. Lead Toxicity from Lead Tetroxide Used in Hobbyist Advanced Model Rocketry. Fedoruk MJ, Hinkson RS, Israel LM, Baker DB.
151. Suicidal Cyanide Deaths in the Hmong Community. Garlich FM, Roberts DJ, Anderson DL, Kalugdan T.
152. Extensive Dermal Hypersensitivity Reaction Related to Dermal Exposure to Diphenylcyclopropenone. Sawyer TS, Oller LK, Lowry JA.
153. A Recent Outbreak of Honey Poisoning Linked to the Tutu Plant (Coriaria arborea). Beasley DM.
154. Improved Access to Reliable Poisons Information in Norway. Lorentzen HR, Tosterud M.
155. Integrating Poison Prevention Training into the EMS CE Program. Dance V, Lemaster J, McGleam P, Metzler P, OConnor M, Woelfel S.
156. Methylmalonic Acidemia (MMA) Presenting as Methanol Toxicity in an Infant. O'Connor AD, Quan D, Curry SC.
157. Incomplete Calls – How Bad Is It?. Chu AF, Ruck B, Rego GR, Marcus S.
158. Changes in Serum Osmolality after Intravnous Contrast Administration. George M, Al-Duaij N, Shannon MW.
159. Postcards in Persia: A Randomized Controlled Trial of an Intervention To Reduce Repetition of Hospital Treated Deliberate Self Poisoning. Sarjami S, Hassanian-Moghaddam H, Kolahi AA, Carter GL.
160. Management of Paediatric Poisoning at a Referral Hospital in Zimbabwe. Gadaga LL, Mufukari N, Tagwireyi D.
161. Increased Anion Gap, Metabolic Acidosis with Prolonged Dexmedetomidine. Farooqi MF, Seifert SA, Benson BE.
162. Neuromuscular Blockade in Poisoned Patients. Rowden AK, Basiaga M, Cadar S, Viloria A, O'Malley GF.
163. Persistent Toxicity after Suboxone Ingestion in a Toddler. McKeown NJ, West PL, Hendrickson RG.
164. Delayed Severe Cardiotoxicity and Prolonged Mental Status Changes Associated with Chronic Lithium Toxicity. Drew B, Miller AD, DeMott MC, Young MC, Clark RF, Ly BT, Schnier AB, Tanen DA.
165. Intravenous Fat Emulsion for Refractory Verapamil and Atenolol Induced Shock: A Human Case Report. Dolcourt BA, Aaron CK.
166. Normal Anion Gap in Aspirin Poisoning. Rowden AK, Herres J, Ryan D, Dymarsky A, Ulitsky A, O'Malley GF.
167. Computerized N-Acetylcysteine Physician Order Entry by Template Protocol for Acetaminophen Toxicity: An Update. Thompson TM, Blackwood LK, Lu JJ, Leikin JB.
168. False-Positive Phencyclidine Urine Immunoassay Screen Due to Tramadol. Ly BT, Stone J, Buono C, Wu AH.
169. Poison Center and Telemedicine Virtual Enhanced ICU Service Collaborate. Kemmerer DA, Goran SF, Van der Kloot TE, Peredy TR.
170. Yew Tree Poisoning Treated with Amiodarone. Bora KM, Smolinske S, Reed P, Devlin W.
171. Adverse Effects Associated with Arginine α-Ketoglutarate Containing Supplements. Prosser JM, Majlesi N, Nelson LS, Olsen D.
172. Quetiapine-Associated Sedation Responding to Naloxone Therapy. Majlesi N, Su MK, Greller HA, Carracio TR, Lee DC, Chan GM.
173. Dextromethorphan Abuse Masquerading as Recurrent Seizure Disorder. Majlesi N, Su MK, Chan GM, Greller HA, Lee DC.
174. A Local Outbreak of Scombroid Fish Poisoning in Japan. Iguchi S, Sugita M, Nomura T, Sekii H, Ookubo H, Yamaguchi N.
175. Tranylcypromine Toxicity Resulting in Thrombocytopenia and Subsequent Thrombocytosis. O'Connor AD.
176. Treating Body Stuffers with Whole Bowel Irrigation; Should We Flush the Procedure?. Bryant SM, Weiselberg R, Metz J, Wahl M, Aks SE.
177. Corneal Ulceration in a Dog Following Walkingstick Envenomation. Brutlag AG, Hovda LR, Della Ripa MA.
178. Pediatric Varenicline (Chantix [R]) Exposures over a 27 Month Period. Banerji S, Bronstein AC.
179. A Complicated Hospitalization Following Dilute Ammonium Chloride Ingestion. Hammond K, Graybill T, Lu JJ, Speiss SE, Leikin JB.
180. Employee Satisfaction Survey Following the Implementation of a Novel Drug Identification Service. Doyon S, Anderson BA, Welsh CJ, Klein-Schwartz W, Hayes BD.
181. Reversal of Atrial Fibrillation in Cyanide Poisoning. Fernández MC, Teter CA, Borron SW.
182. Creative Chemistry: Microwave Extraction of Dextromethorphan from Sucrets®. Weber JA, Scalzo AJ, Tominack RL.
183. Retrospective Review of Ramelteon (Rozerem™) Exposures Reported to a Poison Center Network, 2005–2007. Velez LI, Kirschner R, Forrester MB, Vohra R, Abron D, Benitez FL.
184. Outcomes of Acetaminophen (APAP) Ingestion Patients Unable To Be Classified as Acute or Repeated Supratherapeutic Ingestions (RSTI). Zosel AE, Varney SM, Heard K, Toxicology Investigator Network.
185. Developing Culturally Relevant Consumer Education Materials in Hmong. Simeonov IM, Hamm KM, Heard SE.
186. Maternal and Neonatal Metabolic Acidosis after Ingestion of Oral Anesthetic Spray. Kleiman RJ, Chang AS, Hon SL, Cook CR, Skinner CG, Mathews A, Morgan BW.
187. Case Report of Severe Lactic Acidosis from Iatrogenic Propylene Glycol Overdose. Zosel A, Egelhoff E, Heard K.
188. Prolonged Delirium in a Pediatric Patient after Modafinil and Escitalopram Ingestion. Johnson-Arbor K, Christ M.
189. Lessons To Be Learned: A Poison Center's Use of Digital Call Recordings. Marshall SW, Crouch BI, Caravati EM.
190. Changes in Caller Type for Drug Identification Calls Reported to a Regional Poison Center over Time. Anderson BD, Klein-Schwartz W, Hayes B, Doyon S, Gonzales L.
191. The Truth about AST and ALT in Severe Acetaminophen Overdose. Lavonas EJ, Green JL, Heard KJ, Spyker DA, Ng CM, Rumack BH, Temple AR, Dart RC.
192. Population Exposure Model of Patients Following Acetaminophen Overdose. Ng CM, Spyker DA, Green JL, Lavonas EJ, Heard KJ, Rumack BH, Temple AR, Dart RC.
193. Expanding the Consumer Friendly and Culturally Relevant Line of California Poison Control System Education Products. Simeonov IM, Hamm KM, Heard SE.
194. Lithium Toxicity Reported over 8 Years to One US Poison Center. Martin TG.
195. A Case of Canine Ingestion of Buzz-Bites Chocolate Energy Chews. Alsop JA, Albertson TE.
196. Adverse Outcome with Bloodroot Salve Treatment. Zaret LS, Zusthi D, Cienki JJ.
197. Pediatric Ziprasidone Ingestion Resulting in Respiratory Failure. Gresham C, Ruha AM.
198. Simulated Contaminants for Use in External Decontamination Training. Shepherd G.
199. Use of Olanzapine for Emergency Management in the Agitated Pediatric Patient. Uribe M, Stephan M, Darling B, Feng SY, Goto C.
200. A Case of Atrial Fibrillation Associated with the Administration of Acetadote®. D'Orazio JL, Greenberg M.
201. Amanita smithiana Mushroom Ingestion: A Case of Delayed Renal Failure. West PL, Horowitz BZ.
202. Significant Toxicity Due to Phentermine Ingestion by Young Children: A Case Series. DesLauriers C, Wahl M.
203. Treatment of Severe Pediatric Ethylene Glycol Intoxication with Fomepizole Alone. Murphy NG, Sonier T, Power D, Bona DR.
204. Recommendations Vary Dramatically on the Use of Sodium Bicarbonate for Aspirin and Tricyclic Anti-Depressant Toxicity. Barrera RD, Kleinschmidt KC.
205. Use of Clinical Data-Sets in Mushroom Exposure Management. Hughes K, Wedin GP, Anderson DL.
206. Clonazepam Induced AV Block. Arroyo AM, Kao LW.
207. CEN Standard (EN 15178) for Improvement of Product Identification in Poison Centers. Hahn A, Rickert D.
NACCT DAY 4. Tuesday, September 16, 2008
11:00 AM–12:00 PM Platform Session 6: Adverse Drug Events
Abstracts #208–#211
208. Clinical Course of Repeated Supratherapeutic Ingestion (RSTI) of Acetaminophen (APAP). Alhelail MA, Hoppe JA, Rhyee SH, Heard KJ, Toxicology Investigator Network.
209. Colchicine Toxicity and Fatality among Hospital Patients. Mullins ME, Cannarozzi AA, Bailey TC, Ranganathan P.
210. Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a Regional Burn Center, 1983–2006. O'Connell EJ, Velez LI, Young A, Arnoldo B, Hunt J, Purdue G.
211. Serum Acetaminophen (APAP) Levels, Intravenous N-Acetylcysteine (IV NAC) Infusion Rate and Risk of Anaphylactoid Reactions (AR). Buchanan JA, Phua DH, Mlynarchek SL, Heard K, Toxicology Investigator Network.
7:00 AM–1:00 PM Poster Session III
(Authors with posters Abstracts #212 – #305
10:00 AM–11:00 AM)
212. Declining Presence of Syrup of Ipecac in the Home: Analysis of Questionnaires Prior to and Following the 2003 Publication of the AAP Policy Statement on Poison Treatment in the Home. Judge BS, Trestrail III JH.
213. Seizure Associated with Tramadol Use/Abuse. Talaie H, Panahandeh R, Fayaznouri MR, Asadi Z, Abdollahi M.
214. Assessing Health Insurance Coverage for Callers to a Regional Poison Center: Has the Time Come for Insurers To Foot the Bill?. Judge BS, Eisenga BH, Trestrail III JH.
215. Evaluation of Completeness of Selected Poison Control Center Data Fields. Jaramillo JE, Marchbanks B, Willis B, Forrester MB.
216. Impact Factors, H Indices, and Citation Analyses in Toxicology Journals. Bird SB, Kent K, Church R, Rosenbaum C.
217. Serious Toxicity in an Infant Due to Ingestion of 1 mg Risperidone. Anderson KT, Caravati EM, Seger CJ.
218. Retrospective Review of Modafinil Toxicity. Spiller HA, Borys D, Griffith JRK, Aleguas A, Sollee D, Anderson DA, Klein-Schwartz W, Sawyer T.
219. Comparison of Toxicity of Overdoses with Citalopram and Escitalopram. Hayes BD, Klein-Schwartz W, Clark RF, Muller AA, Miloradovich JE.
220. Intentional Intravenous Epinephrine Overdose from a Crash Cart. Hurley WT, Schultz DA, Ellis SA.
221. Inhalational Mercury Exposure from Attempted Creation of a Hydrogen Fuel Cell. McKeown NJ, Hendrickson RG, Gaines SA, Horowitz BZ.
222. Ketamine-Related Toxicology Presentations to the ED. Wood DM, Bishop CR, Greene SL, Dargan PI.
223. Recreational Drug Toxicity in the Nightclub Environment. Wood DM, Dargan PI.
224. Medical Student's Knowledge of Street Names for Recreational Drugs. Wood DM, Bishop CR, Dargan PI.
225. An Electronic Document Management Program To Improve Preparedness for a Terrorism Incident. Pummer TL, Wisniewski C, Krenzelok EP.
226. Do Most Pediatric Poisonings Occur While a Product Is in Use?. Mrvos R, Krenzelok EP.
227. Crotalidae Polyvalent Immune Fab (CroFab) Therapy for Crotalus durissus terrificus Envenomation. Lynch MJ, Cannon RD.
228. Lack of Utility of X-Ray Compared to CT in Diagnosing Crack Lung. Bonz JW, Kirrane BM, Hoffman RS.
229. Massive Clonidine Suspension Overdose. Farooqi MF, Seifert SA, Kunkel SJ, Johnson MI.
230. “Vitamin” B17 Toxicity Treated with Hydroxocobalamin. Martinelli CJ, Barko IR, O'Toole K, Bayer MJ.
231. Cognitive Impairment in Chronic Occupational Exposure to Organophosphates: Psychophysiological Evidence. Dassanayake T, Gawarammana I, Weerasinghe V, Dissanayake S, Pragaash S, Dawson A, Senanayake N.
232. Factors Associated with Adverse Cardiovascular Events among Patients with Suspected Acute Poisoning. Manini AF, Nelson LS, Skolnick A, Slater W, Hoffman RS.
233. Highest Reported Salicylate Level with Survival. O'Shura JS, Brooks DE, Pizon AF.
234. Graying of Poison Centers. Fladby C, McVoy J, Jacobitz K.
235. A Model for Calculating the Dispersion Distance of Radioiodines in Case of an Accidental Release from a Nuclear Power Plant. Leenders ME, Kok-Palma YS, Meulenbelt J.
236. Analysis of Causes of Therapeutic Errors in Older Adults. Hayes BD, Klein-Schwartz W.
237. Transient Alanine Aminotransferase Elevations in Alcohol Abstaining Subjects with 10 Consecutive Days of Therapeutic Acetaminophen (APAP) Use. Grazi LM, Green JL, Dart RC, Heard K.
238. Pediatric Ingestions of Hand Sanitizers – Debunking the Myth. Mrvos R, Krenzelok EP.
239. Substance Abuse Related Mortality, Iran 2004. Sarjami S, Hassanian-Moghaddam H.
240. Severe Paralytic Ileus Following Lithium Overdose. Hung D, Lin Z, Jan Y.
241. Acute Renal Failure Following Injections of Silicone Dermal Filler by an Unlicensed Practitioner. Sutter ME, Moore Z, Schier J, Thomas JD, Wang RY, Lando J.
242. IPCS INTOX DMS as a Flexible Tool for Management of Data on Toxic Exposures and Multi-Centre Use: The Experience from Brazil. Fruchtengarten LVG, Almeida MVGT, Amaral DA, Tempowski J, Bulkley G, Gu W.
243. Frequency and Timing of Physostigmine Redosing in Anticholinergic Toxidrome. Rosenbaum CD, Bird SB.
244. OTC Product Confusion and Unintentional Salicylism in an Infant. Salinger LM, Wexell K, Nicholson K, Schwartz J, Lang S, Dickenson C, Faraon C, Baum C, Sangalli B, Bayer MJ.
245. Efficacy and Safety of Intravenous Lipid Therapy in a β-Blocker Overdose. Harchelroad FP, Palma A.
246. Office-Based Opioid Addiction Treatment, and the Rise in Unintentional Pediatric Buprenorphine Ingestions Reported to a Regional Poison Center – A New Challenge for Poison Educators. Longfellow C.
247. Validity of the AAPCC Selective Serotonin Reuptake Inhibitor Poisoning Guideline for Escitalopram. Stanford R, Morgan DL, Borys DJ.
248. Effect of the AAPCC Iron Management Guideline on Triage and Outcome of Children's Multivitamin with Iron Ingestions Reported to a Poison Control Center. Anderson KT, Caravati EM, Dahl B, Crouch BI.
249. Observational Study of Spider Bites in Oregon. McKeown NJ, Vetter RS, Hendrickson RG.
250. Medication Identification Requests: A Challenge and an Opportunity. Krenzelok EP, Mrvos R.
251. A Significant Xyrem® Overdose Managed Conservatively Despite High GHB Concentrations. Dargan PI, Jayachandran A, Button J, Davies S, Northall F, Lidder S, Holt DW, Wood DM.
252. Age-Specific Decreases in Penetrance: Evidence for Success in Preventing Pediatric Poisoning?. Lewis-Younger CR, Chambers-Emerson J.
253. Gastric Bypass as a Risk Factor for 3% Hydrogen Peroxide Toxicity. Elko CJ, Talksabout VL.
254. A Fatal Case of Transdermal Fentanyl (TDF) Overdose Discovered Serendipidously. Caraccio TR, Reggio D, Dahm D, McFee R, Yum EK.
255. Prolonged Sedation Following a Pediatric Ingestion of Aripiprazole. Majlesi N, Chan GM, Stanton C, Carracio TR, Greller HA.
256. Fatal Accidental Ingestion of Glyphosate in an Adult. Elko CJ, Muresan NM, Hurley WT.
257. Psychosis Temporally Related to Supratherapeutic Manganese Supplementation. Leikin JB, Mottram AR.
258. Prolonged Acidosis and Coma after Acetazolamide Overdose. George M, Nordstrom CR.
259. Octreotide-Induced Bradycardia in the Treatment of Hypoglycemia Due to Oral Sulfonylurea Overdose. Chew T, Aks SE, Mottram A, Donahue B.
260. A Pilot Study Utilizing a Novel Point of Care Test for Serum Acetaminophen Quantitation. Kapur BM, Thompson MA.
261. Radioactive Products – The Next Category of Toy? Will Parents Be Happy with a Visit from HAZMAT? A Case of Uranium Marbles Purchased over the Internet by Teens. Caraccio TR, McFee RB, Luboweicki DM, Mestel R.
262. A Case of Inhalational Exposure to Palytoxin. Majlesi N, Su MK, Chan GM, Lee DC, Greller HA.
263. Thyroid Storm after Pediatric Ingestion of Levothyroxine. Majlesi N, Su MK, McGuigan MA, Carracio TR, Lee DC, Greller HA, Chan GM.
264. Evaluation of “Spike's” Poison Prevention Curriculum as Implemented in the Child Care Center Environment. Waring ER, Sabo CS, Will KE, Youmans EM.
265. Acetaminophen Induced Hepatotoxicity Despite Early Individualized Treatment. Dolcourt BA, Morrone WR, Smolinske S.
266. Should No Bowel Irrigation Be a Higher Priority Than Whole Bowel Irrigation in the Treatment of Sustained-Release Product Ingestions?. Bryant SM, Weiselberg R, Metz J, Wahl M, Aks SE.
267. Cross-Reactivity of Veratrum viride Steroid Alkaloid Compounds with a Digoxin Clinical Chemistry Assay. Bechtel LK, Lawrence DT, Holstege CP.
268. Perceived Severity of Clinical Effects from Toxic Exposures Reported to a Poison Control Center. Bennett H, Poynton M, Ellington L, Jasti S, Crouch B, Caravati M.
269. Cardiac Toxicity Following Hydroxychloroquine Overdose Despite Early Intervention. Lu JJ, Branzetti J, Cole K, Reaven D, Aks SE, Leikin JB.
270. Acute Pneumonitis and Diffuse Alveolar Hemorrhage after Cosmetic Silicone Injections. Braun MA, Kalimullah EA, Aks SE.
271. Safety Profile of Oral Versus Intravenous N-acetylcysteine for Acute Ingestion of Acetaminophen. Mlynarchek SL, Bogdan GM, Heard K, Dart RC, Toxicology Investigator Network.
272. Gelcap Med Error: IV Administration of Oral 60 mg Nimodipine in an Adult with Aneurysmal Subarachnoid Hemorrhage: Resuscitation from near Arrest. Scalzo AJ, Weber JA.
273. How Opioid-Acetaminophen Overdose Patients Die. Varney SM, Buchanan JA, Lavonas EJ, Campagna EJ, Bailey JE, Dart RC.
274. Analysis of Accidental Acute-on-Chronic Clonidine Ingestions in Children Less Than 12 Years of Age. Skinner CG, Alkhamees W, Frick LJ, Kleiman RJ, Morgan BW, Geller RJ, Chang AS.
275. Puppet's Playful Role in Home Education. Finkelstein GB, Heinen MA, Kundel SK.
276. Hymenoptera Envenomation in Vietnam. Nguyen NT, Thu BH, Schaeffer TH, Phillips SD.
277. Propoxyphene: A Drug with Unfavorable Risk-Benefit Characteristics. Zosel A, Bailey E, Dart R.
278. Persistent Cerebral Edema and Death after Hemodialysis for Chronic Salicylism. Kostic MA, Gummin DD.
279. Severe Rattlesnake Envenomation in a Patient with Idiopathic Thrombocytopenia Purpura (ITP). Buchanan JA, Phillips SD, Schaeffer TH.
280. Rapid Airway Loss (RAL) after Rattlesnake (RS) Envenomation. Schaeffer TH, Phillips SD, Waksman J, Cetaruk E, Kulig K, Brent J.
281. The MALAdy of Metformin Overdose. Is CVVH the Cure?. Arroyo AM, Walroth TA, Mowry J, Kao LW.
282. Effectiveness of a Poison Center Intervention on Product Coding. Kirtland MN, Lemon S, Bailey JE, Dart RC, RADARS® System Poison Center Group.
283. Utilization of Poison Center Services in State CHEMPACK Response Plan. Ryan ML, Arnold TC.
284. Persistent Unilateral Blindness Following Methanol Poisoning. Lu JJ, Kalimullah EA, Bryant SM.
285. The Dangers Associated with Fondaparinux (FDX) and Reversal with Recombinant Factor VIIa. Farmer BM, Duthie E, Nelson LS.
286. Using GIS Tools To Evaluate Common Drugs of Abuse Trends over Time and Location. Anderson BD, Klein-Schwartz W, Hayes B, Doyon S, Jeffrey S.
287. A Case Series of Pseudohyperchloremia and Negative Anion Gap Associated with Acute Salicylate Intoxication. Harchelroad FP, Sawyer KN, Zimmer BW, Marcus RJ.
288. Multiple Intentional Snake Envenomations as Novel Drug-Seeking Behavior. Ryan ML, Arnold TC.
289. Treatment of Methanol Poisoning without Maintenance Doses of Fomepizole during Dialysis. Akhtar J, Campbell MC, Kotagal V, Krenzelok EP.
290. Gone with the Wind: Effects of Katrina/Rita on State Population and Poison Center Utilization. Ryan ML, Arnold TC.
291. Challenges in Detection and Confirmation of Modafinil Use. Gresham C, Wallace KL.
292. Does Addition of Digoxin Immune Fab (DIGIBIND®) to Standard Supportive Care Affect K+ or Length of Stay of Digoxin Toxic Patients?. Reb CR, Diorio G, Verhelst B, O'Malley GF, Giraldo P.
293. Toxic Effects from Human Oral Exposure to 3-Methoxy-3-Methyl-1-Butanol (MMB). Strickland SS, Whitlow KS.
294. A Survey of Philadelphia Area Emergency Departments Regarding Preparedness for Radiation Emergencies. D'Orazio JL, Wilson L, Greenberg MI.
295. Making Conclusions from Serial Cases with No Adverse Outcomes. Kilbourne EM, Geller RJ, Chang AS.
296. Acute Intoxication with Quetiapine: A Cohort Study. Kramer I, Rauber-Luthy C, Kupferschmidt H.
297. A Systematic Review of Animal Studies Using Antipsychotic Medications To Attenuate Cocaine Toxicity. Cleveland NJ, Krier S, Heard K.
298. Results from the Nova Scotia Antidote Kit Project. Murphy NG, Bona DR, Hurley TA.
299. Magnetic Object Bezoar Leading to Small Bowel Perforation. Bora KM, Smolinske S.
300. Epidemiology of Human Poisonings in Chile. Rios JC, Solari S, Bettini M, Mieres JJ, Perez M, Paris E.
301. Fruit-Flavored Cologne – A New Twist on the Look-Alike Problem. Soghoian SE, Nelson LS, Hoffman RS.
302. Vipera palaestinae Bite and Serum Sickness during Pregnancy. Lurie Y, Bentur Y.
303. Acute Pediatric Malahabiya Oil Ingestion: A Case Report. Hughes K, Homme JL, Anderson DL.
304. Pediatric Imidazoline Poisonings as Reported to U.S. Poison Control Centers (USPCC). Lowry JA, Rahman SA.
305. Plasma Concentrations in Two Children with Unintentional Tetrahydrozoline Overdose. Lowry JA, Peat JJ, Garg U, Wasserman GS.